Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127441281 | 12744128 | 1 | I | 20160818 | 20160908 | 20160914 | 20160914 | EXP | SE-MPA-2016-005144 | PHHY2016SE124416 | NOVARTIS | 83.00 | YR | M | Y | 0.00000 | 20160915 | OT | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127441281 | 12744128 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | UNK, 1 X 2 DURING ONE WEEK | 20234 | EXTENDED RELEASE TABLET | |||||||||
| 127441281 | 12744128 | 2 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | UNK, 1 + 0 + 2 DURING ANOTHER WEEK | 20234 | EXTENDED RELEASE TABLET | |||||||||
| 127441281 | 12744128 | 3 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 400 MG, BID (UPPTRAPPNING TILL 2+0+2) | 20234 | 400 | MG | EXTENDED RELEASE TABLET | BID | ||||||
| 127441281 | 12744128 | 4 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | U | 0 | ||||||||||
| 127441281 | 12744128 | 5 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 127441281 | 12744128 | 6 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 127441281 | 12744128 | 7 | C | LEVAXIN | LEVOTHYROXINE SODIUM | 1 | Unknown | U | 0 | TABLET | |||||||||
| 127441281 | 12744128 | 8 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | U | 0 | ||||||||||
| 127441281 | 12744128 | 9 | C | PRIMPERAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 127441281 | 12744128 | 10 | C | DIAZEPAM. | DIAZEPAM | 1 | Unknown | U | 0 | ||||||||||
| 127441281 | 12744128 | 11 | C | ALVEDON | ACETAMINOPHEN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127441281 | 12744128 | 1 | Epilepsy |
| 127441281 | 12744128 | 4 | Product used for unknown indication |
| 127441281 | 12744128 | 5 | Product used for unknown indication |
| 127441281 | 12744128 | 6 | Product used for unknown indication |
| 127441281 | 12744128 | 7 | Product used for unknown indication |
| 127441281 | 12744128 | 8 | Product used for unknown indication |
| 127441281 | 12744128 | 9 | Product used for unknown indication |
| 127441281 | 12744128 | 10 | Product used for unknown indication |
| 127441281 | 12744128 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127441281 | 12744128 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127441281 | 12744128 | Asthenia | |
| 127441281 | 12744128 | Fatigue | |
| 127441281 | 12744128 | Pruritus | |
| 127441281 | 12744128 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127441281 | 12744128 | 1 | 201607 | 0 | ||
| 127441281 | 12744128 | 2 | 201607 | 0 | ||
| 127441281 | 12744128 | 3 | 20160725 | 0 |